Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FACT Study: Fiasp vs Novorapid in Minimed 670G 4.0 for Type 1 Diabetes
NCT04853030Completed
- Sponsor
- Faculty of Medicine, University of Ljubljana
- Start
- Apr 2021
- Primary completion
- Sep 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Randomised, double-blind trial of human insulin in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Faculty of Medicine, University of Ljubljana. Primary endpoint: Time above range 180 mg/dl at 12 weeks. Started Apr 2021; status: completed.
02
Drugs
human insulin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04853030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04853030.